Search results
Results from the WOW.Com Content Network
Instead, during a routine exam or while screening for another health problem, a doctor’s blood panel may show signs of elevated liver enzymes—and early indication of the hepatitis C virus.
Human immunodeficiency virus (HIV) and hepatitis C virus (HCV) co-infection is a multi-faceted, chronic condition that significantly impacts public health.According to the World Health Organization (WHO), 2 to 15% of those infected with HIV are also affected by HCV, increasing their risk of morbidity and mortality due to accelerated liver disease.
The hepatitis C virus (HCV) [3] is a small (55–65 nm in size), enveloped, positive-sense single-stranded RNA virus of the family Flaviviridae. The hepatitis C virus is the cause of hepatitis C and some cancers such as liver cancer ( hepatocellular carcinoma , abbreviated HCC) and lymphomas in humans.
Hepatitis C is spread primarily by blood-to-blood contact, associated with intravenous drug use, poorly sterilized medical equipment, needlestick injuries in healthcare, and transfusions. [2] [4] It may also be spread from an infected mother, to her baby during birth.
Hepatitis C is an infectious disease caused by the hepatitis C virus (HCV) that primarily affects the liver; [2] it is a type of viral hepatitis. [6] During the initial infection period, people often have mild or no symptoms. [1] Early symptoms can include fever, dark urine, abdominal pain, and yellow tinged skin. [1]
The transmission of hepatitis C is through the contact with the blood of the infected person, for example by sharing the needles or by using non-sterile medical equipment. [2] HCV is transmitted globally because of the high infection rate and is also associated with a high mortality rate. [3] [4] The World Health Organization indicates the 3.3% ...
Where to get questions answered. If you have Part B questions, look for answers on Medicare’s site or by calling Medicare (1-800-MEDICARE) or your doctor. Additional reporting by Margie Zable ...
Guidelines for the investigation of babies born to hepatitis C positive mothers have been published. [8] In children born to hepatitis C virus antibody positive but hepatitis C virus RNA negative mothers, the alanine aminotransferase and hepatitis C virus antibodies should be investigated at 18-24 months of life. If both the alanine ...